To achieve this goal, Horizon is delivering a repeatable life science business set to have an increasingly significant impact on 21st century healthcare, enabling our customers to revolutionise how life science research is undertaken, how disease is diagnosed, and how effective treatments are developed.
To achieve this goal, we are delivering a repeatable life science tools business focused on meeting the needs of our customers today, and anticipating their needs for tomorrow, in areas as diverse as personalised medicine, cell and gene therapy (a market estimated to be worth up to £14 billion by 20251), and immuno-oncology (a market currently estimated to be worth £50 billion per year by 20202).
Cells are the functional unit of biology, and all living things are made up of them, from the simplest amoeba to humans. It is at this level where the DNA within each specialised type of cell defines its structure, metabolic processes and role within the organism.
Horizon provides ‘Inspired Cell Solutions’, and the cell is at the heart of all of our activities. We have a clear business focus based around this central vision, with our commercial and research operations designed to ensure that everything we do is aligned around the effective deployment of the cell on behalf of our customers.
We are global leaders in cell engineering
Our unique and innovative technology agnostic platform allows us to control the cell using our expertise in:
Our vision is to unlock the power of the cell
The cell is at the heart of biology. Our ability to modify the cell helps customers understand biology and tranlate knowledge into valuable industrial applications.
We are increasing our focus on customers every day
Our unique tools and services are used by customers to provide valuable insights and applications in: